Assessment of the Glucose Management Indicator Using Different Sampling Durations.

Area of Science:

• Endocrinology
• Metabolic Diseases
• Biomedical Engineering

Background:

• Continuous glucose monitoring (CGM) is crucial for diabetes management.
• The glucose management indicator (GMI) is a key metric derived from CGM data, correlating with HbA1c.
• Determining the optimal duration of CGM data for accurate GMI calculation is essential for clinical practice.

Purpose of the Study:

• To compare the accuracy of GMI calculated using varying durations of CGM data (<14 days) against a 14-day reference period.
• To assess the feasibility of using shorter CGM data periods for reliable GMI estimation in patients with type 1 and type 2 diabetes.

Main Methods:

• Analysis of CGM data from 581 participants with type 1 or type 2 diabetes across five clinical trials.
• Calculation and comparison of GMI values derived from 14-day CGM data versus shorter periods (10, 7, 5, and 3 days).
• Statistical analysis including correlation coefficients and percentage agreement within 0.3% of the 14-day GMI benchmark.

Main Results:

• High correlations were observed between 14-day GMI and GMI calculated from shorter periods (0.95 for 7 days, 0.98 for 10 days).
• Over 87% of GMI values calculated using 7 days of data were within 0.3% of the 14-day GMI.
• While 10-14 days are preferred, 7 days of CGM data yielded a satisfactory GMI estimate for most patients.

Conclusions:

• CGM data from 7 days provides a reliable and satisfactory estimate of GMI, closely mirroring results from longer durations.
• Shorter CGM data periods, particularly 7 days, can be utilized for GMI estimation, offering flexibility in diabetes management.
• These findings support the potential for using reduced CGM data durations without significantly compromising the accuracy of GMI assessment.